Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial - The Lancet Get link Facebook X Pinterest Email Other Apps - March 27, 2020 Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial The Lancet Get link Facebook X Pinterest Email Other Apps Comments
Comments
Post a Comment